Bicocca Open Archive

Logo unimib boa
CRISTOFERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.470
AS - Asia 3.226
EU - Europa 3.223
SA - Sud America 571
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 11.544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.378
SG - Singapore 1.095
IT - Italia 951
CN - Cina 663
VN - Vietnam 578
RU - Federazione Russa 537
HK - Hong Kong 500
BR - Brasile 456
SE - Svezia 453
DE - Germania 452
IE - Irlanda 263
GB - Regno Unito 189
IN - India 82
KR - Corea 70
FR - Francia 67
AR - Argentina 57
ID - Indonesia 52
NL - Olanda 50
FI - Finlandia 48
CA - Canada 46
AT - Austria 30
MX - Messico 28
UA - Ucraina 28
PL - Polonia 25
TR - Turchia 25
ES - Italia 24
IQ - Iraq 24
DK - Danimarca 22
MY - Malesia 22
BD - Bangladesh 21
ZA - Sudafrica 17
BE - Belgio 16
EC - Ecuador 16
JP - Giappone 14
IL - Israele 13
PK - Pakistan 12
CO - Colombia 11
LT - Lituania 11
PY - Paraguay 11
PT - Portogallo 9
UZ - Uzbekistan 9
TW - Taiwan 8
GR - Grecia 7
VE - Venezuela 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
EG - Egitto 6
JO - Giordania 6
MA - Marocco 6
NO - Norvegia 6
SA - Arabia Saudita 6
SK - Slovacchia (Repubblica Slovacca) 6
CL - Cile 5
ET - Etiopia 5
RS - Serbia 5
KE - Kenya 4
MM - Myanmar 4
BO - Bolivia 3
HN - Honduras 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DZ - Algeria 2
GA - Gabon 2
GD - Grenada 2
GH - Ghana 2
IR - Iran 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
PE - Perù 2
TJ - Tagikistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
Totale 11.539
Salva come PNG Salva come JPEG
Città #
Ann Arbor 862
Singapore 715
Hong Kong 493
Ashburn 434
Frankfurt am Main 353
Milan 325
Dublin 248
Fairfield 231
Chandler 220
Wilmington 181
New York 172
Ho Chi Minh City 167
Hefei 152
Chicago 147
Hanoi 131
Beijing 123
Los Angeles 121
Santa Clara 110
Woodbridge 104
London 99
Dallas 97
Seattle 96
Houston 88
Cambridge 81
Princeton 72
Shanghai 68
Seoul 66
Rome 57
Buffalo 54
São Paulo 54
Dearborn 44
Moscow 43
Jakarta 40
The Dalles 40
Lawrence 35
Helsinki 29
Munich 29
Altamura 28
Monza 27
Florence 25
Boardman 21
Haiphong 21
San Diego 21
Warsaw 21
Denver 18
Nuremberg 18
Turin 18
Pune 17
Council Bluffs 16
Nanjing 16
Orem 16
Penang 16
Poplar 16
Biên Hòa 15
Brussels 15
Ninh Bình 15
Rio de Janeiro 15
Brooklyn 14
Jacksonville 14
Salt Lake City 14
Atlanta 13
Can Tho 13
Chennai 13
Da Nang 13
Stockholm 13
Tokyo 13
Vienna 13
Andover 12
Bologna 12
Toronto 12
Ha Long 11
Montreal 11
Phoenix 11
Bari 10
Guarulhos 10
Johannesburg 10
Mexico City 10
Mumbai 10
Paris 10
Boston 9
Campinas 9
Columbus 9
Elk Grove Village 9
Guangzhou 9
Hải Dương 9
Lappeenranta 9
Modena 9
Padova 9
Seregno 9
Tampa 9
Thái Nguyên 9
Turku 9
Curitiba 8
Detroit 8
Lisbon 8
Naples 8
San Francisco 8
Tashkent 8
Ankara 7
Belo Horizonte 7
Totale 7.197
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 516
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 341
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 335
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 287
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 270
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 270
Precision medicine in primary biliary cholangitis 268
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 267
Risk stratification in primary sclerosing cholangitis 266
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 265
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 261
Endocrinology and Metabolic Diseases (Including Diabetes) 254
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 246
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 237
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 236
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 227
New Therapeutic Targets in Autoimmune Cholangiopathies 227
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 215
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 207
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 205
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 203
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 203
Prognostic models in primary biliary cholangitis 201
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 197
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 194
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 190
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 186
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 183
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 180
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 179
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 175
Artificial intelligence for precision medicine in autoimmune liver disease 173
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 167
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 166
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 158
The immunobiology of female predominance in primary biliary cholangitis 156
Fibrocystic liver disease 156
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 155
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 155
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 144
An update on novel pharmacological agents for primary sclerosing cholangitis 142
A Smooth Esophageal Stricture Causing Dysphagia 136
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 132
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 132
X marks the spot in autoimmunity 131
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 131
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 126
Non-invasive imaging biomarkers in chronic liver disease 123
Individualizing Care: Management Beyond Medical Therapy 123
The Role of Epigenetics in Primary Biliary Cholangitis 120
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 120
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 116
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 114
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 111
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 105
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 104
Antioxidant treatment for acute pancreatitis 101
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 96
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 96
Systematic review-Pancreatic involvement in inflammatory bowel disease 93
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 86
Transient elastography in chronic liver disease: beware to the cut-offs! 85
Primary Sclerosing Cholangitis 82
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 81
Individualizing Care: Management Beyond Medical Therapy 72
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 71
Elastography in Autoimmune Liver Diseases 69
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 46
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 41
Totale 11.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.661
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.661
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021741 0 0 0 0 0 121 101 130 89 78 115 107
2021/2022772 100 98 140 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20252.845 195 303 153 143 233 130 191 111 302 421 260 403
2025/20263.599 934 531 494 770 683 187 0 0 0 0 0 0
Totale 11.906